research reports and media, page-2283

No danger of any of us doing it. We'd rather wait (LEGALLY!) and let it play out fairly.

Yes it can seem there aren't many short term milestones to come....don't let this fool you. You don't know what can lift us and when. There are many plays with this one...much in the pipeline. A small example is the MOA doc we got and how @Torpy pointed it out that that was one of the more under the radar news events that picked us up for a full month after the fact.

In my books the chance of a deal for MPS is higher up and before OA. Yes MPS is a lot smaller than the OA program but none the less lucrative with a one day potential of $1 Billion or so revenue per annum. It will get us on the map, it would show just what sort of magic our drug is capable of.


My views